Science Explorer Back to mapMap

Most cited papers in Cancer therapeutics and mechanisms

Cancer therapeutics and mechanisms

What are the most cited papers in Cancer therapeutics and mechanisms?

The most cited paper in Cancer therapeutics and mechanisms is "Cisplatin in cancer therapy: Molecular mechanisms of action" (Shaloam R. Dasari, Paul Bernard Tchounwou, 2014), with 5,600 citations. Next come "Multidrug resistance in cancer: role of ATP–dependent transporters" (5,578) and "Cancer drug resistance: an evolving paradigm" (4,739).

Showing 50 of 100 papers. Every paper with more than 1,006 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Cisplatin in cancer therapy: Molecular mechanisms of action Shaloam R. Dasari, Paul Bernard Tchounwou · European Journal of Pharmacology Open access 21 Jul 2014 5,600
2 Multidrug resistance in cancer: role of ATP–dependent transporters Michael M. Gottesman, Tito Fojo, Susan E. Bates · Nature reviews. Cancer Review 2002 5,578
3 Cancer drug resistance: an evolving paradigm Caitriona Holohan, Sandra Van Schaeybroeck, Daniel B. Longley et al. · Nature reviews. Cancer Review 24 Sep 2013 4,739
4 EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib Susumu S. Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine Open access 23 Feb 2005 3,981
5 Targeting multidrug resistance in cancer Gergely Szakács, Jill K. Paterson, Joseph Aloysius Ludwig et al. · Nature Reviews Drug Discovery Review Mar 2006 3,674
6 Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Lecia Van Dam Sequist et al. · Science Translational Medicine Open access 23 Mar 2011 3,603
7 Cisplatin: mode of cytotoxic action and molecular basis of resistance Zahid Hussain Siddik · Oncogene 20 Oct 2003 3,351
8 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet Open access Mar 2000 3,285
9 FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study Christophe Tournigand, Thierry André, Emmanuel Achille et al. · Journal of Clinical Oncology 8 Dec 2003 2,930
10 The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway Michael R. Lieber · Annual Review of Biochemistry ReviewOpen access 7 Jun 2010 2,911
11 Molecular mechanisms of cisplatin resistance Lorenzo Galluzzi, Laura Senovilla, Ilio Vitale et al. · Oncogene 5 Sep 2011 2,825
12 Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. F Bolivar, Raymond L. Rodriguez, P J Greene et al. · PubMed 1977 2,772
13 DNA Topoisomerases: Structure, Function, and Mechanism James J. Champoux · Annual Review of Biochemistry Review Jun 2001 2,754
14 The NCI60 human tumour cell line anticancer drug screen Robert H. Shoemaker · Nature reviews. Cancer Review 22 Sep 2006 2,696
15 Mechanisms of Cancer Drug Resistance Michael M. Gottesman · Annual Review of Medicine Review Feb 2002 2,665
16 Cellular roles of DNA topoisomerases: a molecular perspective James C. Wang · Nature Reviews Molecular Cell Biology Review Jun 2002 2,368
17 Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Y H Hsiang, Robert Hertzberg, Sidney M. Hecht et al. · Journal of Biological Chemistry Open access Nov 1985 2,367
18 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull et al. · PubMed Sep 1988 2,362
19 Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage Garrett M. Brodeur, Robert C. Seeger, Manfred Schwab et al. · Science 8 Jun 1984 2,295
20 Topoisomerase I inhibitors: camptothecins and beyond Yves G. Pommier · Nature reviews. Cancer Review 22 Sep 2006 2,294
21 A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin DavidA Gewirtz · Biochemical Pharmacology Apr 1999 2,263
22 Neuroblastoma: biological insights into a clinical enigma Garrett M. Brodeur · Nature reviews. Cancer Review 28 Feb 2003 2,204
23 A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science Open access 9 Dec 2004 2,187
24 The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP Cai‐Hong Yun, Kristen E. Mengwasser, Angela V. Toms et al. · Proceedings of the National Academy of Sciences Open access 28 Jan 2008 2,150
25 BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER Suresh V. Ambudkar, Saibal Dey, Christine A. Hrycyna et al. · The Annual Review of Pharmacology and Toxicology Review Apr 1999 2,073
26 Neuroblastoma John M. Maris, Michael D. Hogarty, Rochelle Bagatell et al. · The Lancet Jun 2007 2,049
27 Recent Advances in Neuroblastoma John M. Maris · New England Journal of Medicine Open access 10 Jun 2010 2,025
28 Supercoiling of the DNA template during transcription. Leroy F. Liu, J C Wang · Proceedings of the National Academy of Sciences Open access Oct 1987 2,022
29 The Different Mechanisms of Cancer Drug Resistance: A Brief Review Behzad Mansoori, Ali Mohammadi, Sadaf Davudian et al. · Advanced Pharmaceutical Bulletin Open access 25 Sep 2017 1,924
30 Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Scott H. Kaufmann, Serge Desnoyers, Yvonne Lynn Ottaviano et al. · PubMed Sep 1993 1,922
31 Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy Edgar Pérez‐Herrero, Alberto Fernández‐Medarde · European Journal of Pharmaceutics and Biopharmaceutics Open access 2 Apr 2015 1,888
32 DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs Yves G. Pommier, Elisabetta Leo, Hongliang Zhang et al. · Chemistry & Biology Open access May 2010 1,865
33 DNA TOPOISOMERASES James C. Wang · Annual Review of Biochemistry Jun 1996 1,839
34 Targeting DNA topoisomerase II in cancer chemotherapy John L. Nitiss · Nature reviews. Cancer ReviewOpen access 20 Apr 2009 1,827
35 Mechanisms of Multidrug Resistance in Cancer Chemotherapy Karol Bukowski, Mateusz Kciuk, Renata Kontek · International Journal of Molecular Sciences Open access 2 May 2020 1,812
36 Antibiotics for Emerging Pathogens Michael Andrew Fischbach, Christopher T. Walsh · Science Open access 27 Aug 2009 1,791
37 CYTOCHEMICAL DEMONSTRATION OF SUCCINIC DEHYDROGENASE BY THE USE OF A NEW p-NITROPHENYL SUBSTITUTED DITETRAZOLE Marvin M. Nachlas, K. C. Tsou, EUSTACE DE SOUZA et al. · Journal of Histochemistry & Cytochemistry Open access Jul 1957 1,773
38 DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy Ken André Olaussen, Ariane Dunant, Pierre Jean Fouret et al. · New England Journal of Medicine Open access 6 Sep 2006 1,745
39 Quinoline, quinazoline and acridonealkaloids Joseph P. Michael · Natural Product Reports 17 Dec 2007 1,721
40 Molecular mechanisms of drug resistance DB Longley, PG Johnston · The Journal of Pathology Open access 2005 1,690
41 Small-cell lung cancer Charles M. Rudin, Elisabeth M. Brambilla, Corinne Faivre Finn et al. · Nature Reviews Disease Primers ReviewOpen access 14 Jan 2021 1,632
42 γH2AX and cancer William M. Bonner, Christophe E. Redon, Jennifer S. Dickey et al. · Nature reviews. Cancer ReviewOpen access 13 Nov 2008 1,632
43 γH2AX: a sensitive molecular marker of DNA damage and repair L-J Mah, Assam El‐Osta, Tom C. Karagiannis · Leukemia 4 Feb 2010 1,595
44 Molecular mechanisms that confer antibacterial drug resistance Christopher T. Walsh · Nature 17 Aug 2000 1,587
45 Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen Michael R. Boyd, Kenneth D. Paull · Drug Development Research Feb 1995 1,565
46 Expression of a multidrug-resistance gene in human tumors and tissues. Antonio Tito Fojo, Kazumitsu Ueda, Dennis J. Slamon et al. · Proceedings of the National Academy of Sciences Open access 1987 1,555
47 Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II K M Tewey, Thomas C. Rowe, Liu Yang et al. · Science 26 Oct 1984 1,551
48 Double-Strand Break End Resection and Repair Pathway Choice Lorraine S. Symington, Jean Gautier · Annual Review of Genetics Review 2 Mar 2011 1,540
49 Autoradiographic Study of Cell Migration during Histogenesis of Cerebral Cortex in the Mouse Jay B. Angevine, Richard L. Sidman · Nature Nov 1961 1,537
50 Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer Robert J. Mayer et al. · New England Journal of Medicine Open access 13 May 2015 1,457

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.